188 related articles for article (PubMed ID: 16865243)
1. Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer.
Oida Y; Yamazaki H; Tobita K; Mukai M; Ohtani Y; Miyazaki N; Abe Y; Imaizumi T; Makuuchi H; Ueyama Y; Nakamura M
Oncol Rep; 2006 Sep; 16(3):457-63. PubMed ID: 16865243
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
3. Poor outcome of patients with pulmonary adenocarcinoma showing decreased E-cadherin combined with increased S100A4 expression.
Miyazaki N; Abe Y; Oida Y; Suemizu H; Nishi M; Yamazaki H; Iwasaki M; Inoue H; Ueyama Y; Nakamura M
Int J Oncol; 2006 Jun; 28(6):1369-74. PubMed ID: 16685438
[TBL] [Abstract][Full Text] [Related]
4. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
[TBL] [Abstract][Full Text] [Related]
5. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
Pedersen KB; Nesland JM; Fodstad Ø; Maelandsmo GM
Br J Cancer; 2002 Nov; 87(11):1281-6. PubMed ID: 12439718
[TBL] [Abstract][Full Text] [Related]
6. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer.
Ai KX; Lu LY; Huang XY; Chen W; Zhang HZ
World J Gastroenterol; 2008 Mar; 14(12):1931-5. PubMed ID: 18350635
[TBL] [Abstract][Full Text] [Related]
8. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer].
Qi RX; Xu XY
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.
Kimura K; Endo Y; Yonemura Y; Heizmann CW; Schafer BW; Watanabe Y; Sasaki T
Int J Oncol; 2000 Jun; 16(6):1125-31. PubMed ID: 10811984
[TBL] [Abstract][Full Text] [Related]
10. Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis.
Huang S; Zheng J; Huang Y; Song L; Yin Y; Ou D; He S; Chen X; Ouyang X
Dis Markers; 2016; 2016():8137378. PubMed ID: 26903691
[TBL] [Abstract][Full Text] [Related]
11. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma.
Moriyama-Kita M; Endo Y; Yonemura Y; Heizmann CW; Miyamori H; Sato H; Yamamoto E; Sasaki T
Cancer Lett; 2005 Dec; 230(2):211-8. PubMed ID: 16297707
[TBL] [Abstract][Full Text] [Related]
12. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
[TBL] [Abstract][Full Text] [Related]
13. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
[TBL] [Abstract][Full Text] [Related]
14. The expression of S100A4 in human pancreatic cancer is associated with invasion.
Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK
J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
[TBL] [Abstract][Full Text] [Related]
17. EZH2 Mediates the Regulation of S100A4 on E-cadherin Expression and the Proliferation, Migration of Gastric Cancer Cells.
Liu S; Chen D; Shen W; Chen L; Yu A; Fu H; Sun K; Sun X
Hepatogastroenterology; 2015 May; 62(139):737-41. PubMed ID: 26897964
[TBL] [Abstract][Full Text] [Related]
18. Methylation-associated silencing of S100A4 expression in human epidermal cancers.
Li Y; Liu ZL; Zhang KL; Chen XY; Kong QY; Wu ML; Sun Y; Liu J; Li H
Exp Dermatol; 2009 Oct; 18(10):842-8. PubMed ID: 19703228
[TBL] [Abstract][Full Text] [Related]
19. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
20. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro.
Li N; Song MM; Chen XH; Liu LH; Li FS
Biomed Environ Sci; 2012 Aug; 25(4):465-70. PubMed ID: 23026527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
